CZ20012540A3 - 2,3-O-izopropylidenové deriváty monosacharidů jako inhibitory buněčné adheze a způsob jejich přípravy - Google Patents

2,3-O-izopropylidenové deriváty monosacharidů jako inhibitory buněčné adheze a způsob jejich přípravy Download PDF

Info

Publication number
CZ20012540A3
CZ20012540A3 CZ20012540A CZ20012540A CZ20012540A3 CZ 20012540 A3 CZ20012540 A3 CZ 20012540A3 CZ 20012540 A CZ20012540 A CZ 20012540A CZ 20012540 A CZ20012540 A CZ 20012540A CZ 20012540 A3 CZ20012540 A3 CZ 20012540A3
Authority
CZ
Czechia
Prior art keywords
isopropylidene
deoxy
xylo
hexulofuranose
dodecyl
Prior art date
Application number
CZ20012540A
Other languages
Czech (cs)
English (en)
Inventor
Sudershan K. Arora
Nawal Kishore
Jang Bahadur Gupta
Vishwas D. Joshi
Original Assignee
Ranbaxy Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ranbaxy Laboratories Limited filed Critical Ranbaxy Laboratories Limited
Publication of CZ20012540A3 publication Critical patent/CZ20012540A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/02—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing only oxygen as ring hetero atoms
    • C07H9/04—Cyclic acetals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Diabetes (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Pulmonology (AREA)
  • Molecular Biology (AREA)
  • Rheumatology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Transplantation (AREA)
  • Psychiatry (AREA)
  • Surgery (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Dermatology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CZ20012540A 1999-01-15 2000-01-10 2,3-O-izopropylidenové deriváty monosacharidů jako inhibitory buněčné adheze a způsob jejich přípravy CZ20012540A3 (cs)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN86DE1999 IN190975B (enExample) 1999-01-15 1999-01-15
US09/276,368 US6590085B1 (en) 1999-01-15 1999-03-25 Derivatives of monosaccharides as cell adhesion inhibitors

Publications (1)

Publication Number Publication Date
CZ20012540A3 true CZ20012540A3 (cs) 2002-02-13

Family

ID=11088155

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ20012540A CZ20012540A3 (cs) 1999-01-15 2000-01-10 2,3-O-izopropylidenové deriváty monosacharidů jako inhibitory buněčné adheze a způsob jejich přípravy

Country Status (30)

Country Link
US (5) US6590085B1 (enExample)
EP (1) EP1147119B1 (enExample)
JP (1) JP2002534530A (enExample)
CN (1) CN1167707C (enExample)
AR (1) AR022235A1 (enExample)
AT (1) ATE250074T1 (enExample)
AU (1) AU768511B2 (enExample)
BG (1) BG105745A (enExample)
BR (1) BR0007553A (enExample)
CA (1) CA2359986A1 (enExample)
CO (1) CO5180591A1 (enExample)
CR (1) CR6423A (enExample)
CZ (1) CZ20012540A3 (enExample)
DE (1) DE60005300T2 (enExample)
DK (1) DK1147119T3 (enExample)
ES (1) ES2206176T3 (enExample)
HR (1) HRP20010529B1 (enExample)
HU (1) HUP0105116A3 (enExample)
ID (1) ID30351A (enExample)
IN (1) IN190975B (enExample)
MA (1) MA25342A1 (enExample)
MX (1) MXPA01007187A (enExample)
MY (1) MY121135A (enExample)
NZ (2) NZ512852A (enExample)
PA (1) PA8489901A1 (enExample)
PT (1) PT1147119E (enExample)
SK (1) SK284241B6 (enExample)
TR (1) TR200102043T2 (enExample)
WO (1) WO2000042054A1 (enExample)
YU (1) YU50701A (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd
SG141430A1 (en) 2003-05-30 2008-04-28 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as hmg-co inhibitors
EP1789428A1 (en) * 2004-09-02 2007-05-30 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20100113371A9 (en) * 2004-12-22 2010-05-06 Ranbaxy Laboratories Limited Inc. Derivatives Of Pentose Monosaccharides As Anti-Inflammatory Compounds
EP1915160A2 (en) * 2005-07-22 2008-04-30 Ranbaxy Laboratories Limited Derivatives of monosaccharides for the treatment of copd and allergic rhinitis
BRPI0618379A2 (pt) * 2005-11-08 2011-08-30 Ranbaxy Lab Ltd processo para preparação do hemi-sal de cálcio do ácido (3r,5r) -7-[2-(4-fluorofenil)-5-isopropil-3-fenil-4-[(4-hidroxime tilfenilamino) carbonil]-pirrol-1-il] -3, 5-diidroxi heptanóico
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
US20080114031A1 (en) * 2006-03-29 2008-05-15 Sattigeri Viswajanani J Monosaccharide derivatives
US7790689B2 (en) * 2006-05-30 2010-09-07 Ranbaxy Laboratories Limited Monosaccharide derivatives
US20080300196A1 (en) * 2006-10-03 2008-12-04 Ashwani Kumar Verma Monosaccharide derivatives
US10034995B2 (en) * 2007-09-20 2018-07-31 Resmed Limited Retractable tube for CPAP

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2715121A (en) 1950-09-09 1955-08-09 American Home Prod Alkyl sugar derivatives and their preparation
US4056322A (en) 1973-12-14 1977-11-01 Strategic Medical Research Corporation Preparation of ethers of monosaccharides
US4735934A (en) 1981-02-17 1988-04-05 Greenwich Pharmaceuticals Incorporated Method of therapeutically treating a warm blooded animal afflicted with an autoimmune disease
US4996195A (en) * 1989-01-09 1991-02-26 Greenwich Pharmaceuticals Inc. Derivatives of α,D-glucofuranose or α,D-allofuranose and intermediates for preparing these derivatives
US5010058A (en) 1989-06-22 1991-04-23 501 Greenwich Pharmaceuticals Incorporated 3,5,6-substituted derivatives of 1,2-O-isopropylidene-α,D-glucofuranose and intermediates for preparing these derivatives
FR2652540B1 (fr) 1989-10-02 1995-06-02 Imaje Sa Circuit d'encre notamment destine a la mise en pression d'une encre a pigments pour imprimante a jet d'encre.
US5192746A (en) 1990-07-09 1993-03-09 Tanabe Seiyaku Co., Ltd. Cyclic cell adhesion modulation compounds
US5258402A (en) 1992-06-11 1993-11-02 Mcneil-Ppc, Inc. Imidate derivatives of pharmaceutically useful anticonvulsant sulfamates
US5432163A (en) 1992-11-13 1995-07-11 Greenwich Pharmaceuticals Incorporated Anti-proliferative and anti-inflammatory compounds: derivatives of pentose monosaccharides
US5637570A (en) * 1995-05-09 1997-06-10 Chemora Pharmochem Disubstituted and trisubstituted derivatives of 2,3:4,6-di-O-isopropylidene-α-L-xylo-2-hexulofuranosonic acid having anti-cancer, anti-inflammatory and anti-proliferative activity
IN190975B (enExample) * 1999-01-15 2003-09-06 Ranbaxy Lab Ltd

Also Published As

Publication number Publication date
AU768511B2 (en) 2003-12-18
US6590085B1 (en) 2003-07-08
HK1041270A1 (en) 2002-07-05
ID30351A (id) 2001-11-22
NZ512852A (en) 2004-02-27
TR200102043T2 (tr) 2001-11-21
US20040023900A1 (en) 2004-02-05
HRP20010529B1 (en) 2005-02-28
CO5180591A1 (es) 2002-07-30
CN1343213A (zh) 2002-04-03
WO2000042054A1 (en) 2000-07-20
MY121135A (en) 2005-12-30
HUP0105116A2 (hu) 2003-04-28
US7037899B2 (en) 2006-05-02
JP2002534530A (ja) 2002-10-15
CR6423A (enExample) 2004-03-09
DE60005300D1 (de) 2003-10-23
YU50701A (sh) 2005-06-10
EP1147119A1 (en) 2001-10-24
BG105745A (en) 2002-05-31
US7005516B2 (en) 2006-02-28
MXPA01007187A (es) 2002-04-24
SK10132001A3 (sk) 2002-01-07
AU1886100A (en) 2000-08-01
ATE250074T1 (de) 2003-10-15
US7005422B2 (en) 2006-02-28
DK1147119T3 (da) 2004-01-19
ES2206176T3 (es) 2004-05-16
PA8489901A1 (es) 2000-09-29
HUP0105116A3 (en) 2003-05-28
AR022235A1 (es) 2002-09-04
DE60005300T2 (de) 2004-07-15
PT1147119E (pt) 2004-02-27
NZ527483A (en) 2005-02-25
CN1167707C (zh) 2004-09-22
SK284241B6 (en) 2004-11-03
US20040019191A1 (en) 2004-01-29
CA2359986A1 (en) 2000-07-20
US20040018995A1 (en) 2004-01-29
HRP20010529A2 (en) 2002-08-31
BR0007553A (pt) 2001-12-18
MA25342A1 (fr) 2001-12-31
US20040029820A1 (en) 2004-02-12
EP1147119B1 (en) 2003-09-17
IN190975B (enExample) 2003-09-06

Similar Documents

Publication Publication Date Title
US6329344B1 (en) Derivatives of monosaccharides as cell adhesion inhibitors
EP1147119B1 (en) 2,3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
JPH02200691A (ja) リゾスフィンゴ脂質誘導体
DK173952B1 (da) Anvendelse af spergualinderivater til fremstilling af lægemidler med immunosuppressiv virkning
US4182757A (en) Novel nitrosourea compounds and process for preparing the same
US4472379A (en) Nitrosourea derivatives
AU2024271907A1 (en) Hdac1/2 selective inhibitor and use thereof
HK1041270B (en) 2,-3-o-isoproylidene derivatives of monosaccharides as cell adhesion inhibitors
EP0366560A1 (fr) Nouveaux dérivés de la tylosine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent
JP4841560B2 (ja) 乾癬の処置のためのアミグダリン類似体の使用
KR20150051016A (ko) 구아니딘 화합물 및 이의 용도
Wei Syntheses and characterization of diastereomeric 4, 5-dihydroxy-1, 2-cyclohexanediyl bis (2, 6-dioxopiperazine) S for antitumor, antimetastatic and cardioprotective studies
MXPA01007089A (en) Derivatives of monosaccharides as cell adhesion inhibitors